Top 5 Growth Stocks To Invest In 2018

&l;span&g;The move in the 10-year yield was&a;nbsp;the story of the day today.&a;nbsp; Yields broke back above 3% mark, and moved to a new seven-year high.&l;/span&g;

&l;a href=&q;https://blogs-images.forbes.com/bryanrich/files/2018/05/may15-10s.jpg&q; target=&q;_blank&q;&g;&l;img class=&q;size-full wp-image-4256&q; src=&q;http://blogs-images.forbes.com/bryanrich/files/2018/05/may15-10s.jpg?width=960&q; alt=&q;&q; data-height=&q;340&q; data-width=&q;640&q;&g;&l;/a&g;

That fueled a rally in the dollar.&a;nbsp; &a;nbsp;And it put pressure on stocks, for the day.

We&a;rsquo;re starting to see more economic data roll&a;nbsp;in, which&a;nbsp;should continue building the story of a hotter global economy. And it&a;rsquo;s often said that the bond market is smarter than the stock market.&a;nbsp;&a;nbsp;There&a;rsquo;s probably a good signal to be taken from the&a;nbsp;bond&a;nbsp;market&a;nbsp;that has pushed the 10-year yield back to 3% and beyond (today).&a;nbsp; It&a;rsquo;s a story of better growth and growing price pressures, which finally represents confidence and demand in the economy.

Top 5 Growth Stocks To Invest In 2018: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Max Byerly]

    McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings.
    Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share.
    California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings.
    Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results.
    Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter.
    Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results.
    Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results.
    B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings.
    HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

Top 5 Growth Stocks To Invest In 2018: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Stock No. 3: Let’s go back to the well. So, April last year what was the “I?” Quick quiz at home? That’s right. It was Intuitive Surgical(NASDAQ:ISRG). I own the company, and in front of my gathered fellow Heels last week, I put Intuitive Surgical on this list, as well, so I present it for you again today. It reminds us to continue to add to our winners. It was a winner a year ago. It had a three for one stock split, something that I don’t personally care about. I don’t think we should spend a lot of time talking about stock splits. I realize some people think they’re exciting or are confused by them.

  • [By Motley Fool Staff]

    In the healthcare world, one of those has to be the impressive quarterly report from Intuitive Surgical(NASDAQ:ISRG). The company increased its revenue by 25%, and accelerated its sales of the da Vinci robotic surgical systems that made it famous. But it’s not just the expensive hardware that is allowing it to prosper — it’s that every machine needs a steady supply of the disposable instruments and accessories used during its procedures. The Fools consider the recent numbers, the outlook, and the investment thesis for Intuitive Surgical stock. But in the, say, anti-healthcare space, cigarette slingerPhilip Morris International(NYSE:PM) took a big hit as demand slackened in major foreign markets. Sales of its e-cig devices are also not growing the way management had hoped.

  • [By Motley Fool Staff]

    Stock No. 4: Let’s go to the “I” stock from our April stocks a year ago. That’s one of my favorite companies, a stock that I own, and have held for more than a decade, and that would be Intuitive Surgical (NASDAQ:ISRG), the maker of the da Vinci robot, the surgical robot.

  • [By ]

    As of the time of this article, home cleaning robot maker iRobot’s (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical  (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.

  • [By Motley Fool Staff]

    In this segment fromMarketFoolery, host Chris Hill and Motley Fool Asset Management’s Bill Barker consider the case for healthcare innovator Intuitive Surgical(NASDAQ:ISRG), which has been on a tear for the past few years. Its pricey robots are growing ever more common and popular with hospitals and doctors, and based on the reaction of the market, investors must expect its current sales growth pace to continue.

Top 5 Growth Stocks To Invest In 2018: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By Chris Lange]

    Look for Nordstrom Inc. (NYSE: JWN) to reveal its fiscal fourth-quarter results on Thursday as well. The consensus analyst estimates are $1.25 in EPS and revenue of $4.62 billion. Shares of Nordstrom closed at $53.56 on Friday, above the consensus price target of $49.94. The 52-week range is $37.79 to $54.00.

  • [By ]

    Some reasons for my bearishness on retail stocks:

    Higher Energy Prices. Oil prices have rallied dramatically and back to 2014 levels, rising from about $35 a barrel in early 2016 to around $67 Thursday. That’s bad news for U.S. retailers, as rising oil prices historically squeeze consumer disposable incomes. That’s one reason why I’ve been consistently raising my short exposure to retail and plan to continue doing so. Shaky Same-Store Sales Growth. Recent improvements to same-store sales at Abercrombie & Fitch (ANF) , Urban Outfitters (URBN) , Dillard’s (DDS) , Gap Inc. (GPS) and Macy’s (M) come against downgraded expectations, and might not be sustainable anyway. No Deal for Nordstrom (JWN) . The Nordstrom family has apparently abandoned plans to take its namesake company private. I had expressed concerns that this would happen. Higher Interest Rates. A rise in the London Inter-Bank Offered Rate (LIBOR) has recently accelerated. That’s bad news for retailers, as many variable-rate consumer debts (particularly mortgages) key off of the LIBOR. This will likely put a damper on mortgage refinancings — something that many see as an important ingredient for personal-consumption expenditures.

  • [By JJ Kinahan]

    This week brings a string of retail results with reports from Walmart Inc. (NYSE: WMT) on Thursday morning and Nordstrom, Inc. (NYSE: JWN) after market close the same day. Next week, big-box retailer Target Corporation (NYSE: TGT) and home improvement retailer Lowe’s Companie, Inc. (NYSE: LOW) both report before market open on Wednesday, May 23. For a look at what else is going on across markets, check out today’s market update if you have time.

  • [By ]

    Cramer and the AAP team say today’s weakness is the opportunity they have been patiently waiting for. Their target? Nordstrom (JWN) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Top 5 Growth Stocks To Invest In 2018: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainmenttripling in valuebefore falling back whilesmall cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small capBuffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arbys Restaurant Group:

Top 5 Growth Stocks To Invest In 2018: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.